Skip to content
OpenCapital
Get started

Lexicon Pharmaceuticals LXRX Enterprise value

Enterprise value at other companies

Eli Lilly logo
Eli LillyLLY
$859.77B+10.6%
Pfizer logo
PfizerPFE
$222.4B+9.2%
Merck & Co. logo
Merck & Co.MRK
$341.11B+34.2%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$109.92B-9.5%
Cytokinetics logo
CytokineticsCYTK
$8.41B+70.7%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$452.74M+5.3%

Other financials

Income statement

See full
Revenue$21.1M+1,572%
Gross profit$21.0M+1,604%
Operating income-$996.0K+96.1%
Net income-$1.0M+95.9%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$67.1M+6.7%
Total debt$57.7M-45.7%
Total equity$202.9M+64.9%
Total assets$268.8M-9.7%

Cash flow

See full
Operating cash flow-$14.7M+66.4%
CapEx--100%
Free cash flow-$17.2M+21.5%

Valuation

See full
Market cap$986.12M+262%
P/S14.2×+5.4×

Profitability

See full
Gross margin99.5%+1.5pp
Operating margin-34.8%-16.8pp
Net margin-37.5%-18.1pp
FCF margin-578.5%-283pp

Returns & leverage

See full
Return on equity-16%-7.2pp
Debt / equity0.3×-0.6×
Current ratio18.8×+16.6×

Where this comes from

Calculated from Lexicon Pharmaceuticals’s reported figures.

$660.9Mmarket cap+$57.7Mtotal debt−$67.1Mcash and equivalents=$651.56M

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lexicon Pharmaceuticals's enterprise value?
Lexicon Pharmaceuticals (LXRX) reported enterprise value of $651.56M in Q1 2026.
How has Lexicon Pharmaceuticals's enterprise value changed year-over-year?
Lexicon Pharmaceuticals's enterprise value increased by 210.3% year-over-year, from $209.95M to $651.56M.
What is the long-term trend for Lexicon Pharmaceuticals's enterprise value?
Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's enterprise value has grown at a 1.1% compound annual growth rate (CAGR), from $395.16M to $416.82M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.